Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All case investigation)

Trial Identifier: D9603C00001
Sponsor: AstraZeneca
Start Date: June 2022
Primary Completion Date: August 2026
Study Completion Date: August 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Japan Tottori, Japan